Vithas and GenesisCare partner to launch an oncology center of excellence in Madrid
Vithas y GenesisCare se alían para lanzar un centro oncológico de excelencia en Madrid
Intel ID : 342131
|
||||
| Intel ID | 342131 | ||
| Value | ND | ||
| Native Currency | Euro (EUR) | ||
|
Financial Data - Vithas
(31 Dec 2023) |
Revenue: - EBITDA: - Net Debt: - |
||
| Date |
 |
||
| Country | |
||
| Geography | |
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Subsector (TTRSC) |
30.05.11 Oncology (Primary) 30 Healthcare / 30.05 Specialized Medicine |
||
| Type |
 |
||
| Intel Grade |
|
||
| Source |
|
||
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.05.11 Oncology 30 Healthcare / 30.05 Specialized Medicine |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.03.08 Hospitals 30 Healthcare / 30.03 Healthcare Facilities & Services |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legal Advisory
| Parties | Advisor | Type | Notes from Advisors | |||||
|---|---|---|---|---|---|---|---|---|
|
-
- - - - - - |
- | - |
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.